146
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report

ORCID Icon, , , , , , , & show all
Pages 70-73 | Received 29 Mar 2019, Accepted 25 May 2019, Published online: 20 Jun 2019

References

  • Combe B, Landewe R, Daien CI, et al. 2016 Update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017;76:948–959.
  • Chen M, Gao Y, Guo XH, et al. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol. 2012;8:476–483.
  • Clark SR, Warren NS, Kim G, et al. Elevated clozapine levels associated with infection: a systematic review. Schizophr Res. 2018;192:50–56.
  • Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43:405–413.
  • Gao Y, Zhao MH. Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology. 2009;14:33–41.
  • Radić M, Martinović Kaliterna D, Radić J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med. 2012;70:12–17.
  • Jaunkalns R, Shear NH, Sokoluk B, et al. Antimyeloperoxidase antibodies and adverse reactions to clozapine. Lancet. 1992;339:1611–1612.
  • Voulgari C, Giannas R, Paterakis G, et al. Clozapine-induced late agranulocytosis and severe neutropenia complicated with streptococcus pneumonia, venous thromboembolism, and allergic vasculitis in treatment-resistant female psychosis. Case Rep Med. 2015;2015:1.
  • Penaskovic KM, Annamraju S, Kraus JE. Clozapine-induced allergic vasculitis. Am J Psychiatry. 2005;162:1543.
  • Grau RG. Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep. 2015;17:71.
  • Gao Y, Ye H, Yu F, et al. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin Immunol. 2005;117:87–93.
  • Fujieda M, Hattori M, Kurayama H, et al. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol. 2002;13:437–445.
  • Nakazawa D, Tomaru U, Suzuki A, et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64:3779–3787.
  • Irizarry-Caro JA, Carmona-Rivera C, Schwartz DM, et al. Brief report: drugs implicated in systemic autoimmunity modulate neutrophil extracellular trap formation. Arthritis Rheumatol. 2018;70:468–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.